MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

Por Jakobsen, K R, Demuth, C, Madsen, A T, Hussmann, D, Vad-Nielsen, J, Nielsen, A L, Sorensen, B S
Publicado no Oncogenesis (2017)